FDA recall D-0476-2024

Imprimis NJOF, LLC · Class II · drug

Product

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08

Reason for recall

Subpotent Drug

Distribution

U.S. Nationwide

Key facts

Status: Ongoing
Initiation date: 2024-04-10
Report date: 2024-05-08
Voluntary/Mandated: Voluntary: Firm initiated
Location: Ledgewood, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0476-2024